20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Neurocrine Biosciences Inc (NBIX) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in San Diego, United States with about 2,500 employees. Its market capitalization is roughly $15 billion. In the fiscal year ended 2025-12-31, NBIX reported $2.9B in revenue and $479M in net income.
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
Interactive charts & full statements → Open the NBIX valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.4B | $2.9B | $2.4B | $1.9B | $1.5B | $1.1B | $1.0B | $788M | $451M | $162M | $15M | $20M | $0M | $3M | $53M | $77M | $34M | $3M | $4M | $1M | $39M |
| Gross Profit | $3.3B | $2.8B | $2.3B | $1.8B | $1.5B | $1.1B | $1.0B | $781M | $446M | $160M | $15M | $20M | ($14M) | ($11M) | $42M | $77M | $34M | $3M | $4M | $1M | $39M |
| Gross Margin % | 98.0% | 98.2% | 98.6% | 97.9% | 98.4% | 98.7% | 99.0% | 99.1% | 98.9% | 99.2% | 100.0% | 100.0% | — | -372.8% | 78.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income (EBIT) | $789M | $619M | $570M | $251M | $249M | $102M | $163M | $72M | $37M | ($131M) | ($147M) | ($94M) | ($64M) | ($50M) | $1M | $34M | ($14M) | ($54M) | ($87M) | ($212M) | ($113M) |
| Operating Margin % | 23.4% | 21.6% | 24.2% | 13.3% | 16.7% | 9.0% | 15.6% | 9.2% | 8.2% | -81.3% | -982.5% | -476.5% | — | -1701.9% | 2.7% | 43.8% | -41.0% | -1817.5% | -2196.2% | -17340.0% | -288.8% |
| Net Income | $706M | $479M | $341M | $250M | $154M | $90M | $407M | $37M | $21M | ($143M) | ($141M) | ($89M) | ($61M) | ($46M) | $5M | $38M | ($8M) | ($51M) | ($89M) | ($207M) | ($107M) |
| Net Margin % | 20.9% | 16.7% | 14.5% | 13.2% | 10.4% | 7.9% | 38.9% | 4.7% | 4.7% | -88.2% | -940.6% | -449.8% | — | -1579.0% | 9.5% | 48.5% | -23.8% | -1728.3% | -2229.3% | -16936.2% | -273.2% |
| EBITDA | — | $667M | $640M | $416M | $265M | $138M | $148M | $86M | $41M | ($121M) | ($140M) | ($88M) | ($64M) | ($49M) | $2M | $35M | ($12M) | ($48M) | ($74M) | ($203M) | ($103M) |
| Earnings Per Share (EPS) | $6.84 | $4.67 | $3.29 | $2.47 | $1.56 | $0.92 | $4.16 | $0.39 | $0.22 | $-1.62 | $-1.63 | $-1.05 | $-0.81 | $-0.69 | $0.08 | $0.67 | $-0.15 | $-1.30 | $-2.30 | $-5.45 | $-2.84 |
| Shares Outstanding (M) | — | 102M | 104M | 101M | 99M | 98M | 98M | 96M | 95M | 88M | 87M | 84M | 75M | 67M | 67M | 56M | 53M | 39M | 38M | 38M | 38M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $959M | $814M | $806M | $795M | $688M | $573M | $628M | $622M | $590M |
| Gross Profit | $936M | $801M | $788M | $781M | $676M | $563M | $618M | $614M | $581M |
| Gross Margin % | 97.6% | 98.3% | 97.8% | 98.2% | 98.4% | 98.4% | 98.5% | 98.7% | 98.4% |
| Operating Income (EBIT) | $153M | $186M | $211M | $239M | $146M | $24M | $142M | $184M | $145M |
| Operating Margin % | 16.0% | 22.8% | 26.2% | 30.1% | 21.2% | 4.1% | 22.6% | 29.5% | 24.6% |
| Net Income | $144M | $198M | $154M | $210M | $108M | $8M | $103M | $130M | $65M |
| Net Margin % | 15.0% | 24.3% | 19.1% | 26.4% | 15.6% | 1.4% | 16.4% | 20.9% | 11.0% |
| EBITDA | — | $254M | $235M | $300M | $167M | $31M | $182M | $191M | $155M |
| Earnings Per Share (EPS) | $1.39 | $1.91 | $1.50 | $2.04 | $1.06 | $0.08 | $1.00 | $1.24 | $0.63 |
| Shares Outstanding (M) | — | 103M | 102M | 102M | 101M | 102M | 103M | 104M | 104M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $898M | $783M | $595M | $390M | $339M | $256M | $228M | $147M | $101M | ($94M) | ($106M) | ($38M) | ($47M) | ($30M) | ($35M) | ($1M) | $50M | ($53M) | ($74M) | ($59M) | ($99M) |
| Capital Expenditures (CapEx) | $32M | $34M | $38M | $28M | $16M | $23M | $11M | $15M | $25M | $7M | $4M | $2M | $2M | $1M | $1M | $1M | $0M | $0M | $1M | $1M | $3M |
| Free Cash Flow (FCF) | $866M | $749M | $557M | $362M | $323M | $233M | $218M | $132M | $77M | ($101M) | ($110M) | ($40M) | ($49M) | ($30M) | ($36M) | ($1M) | $50M | ($53M) | ($75M) | ($60M) | ($102M) |
| FCF Margin % | 25.7% | 26.2% | 23.7% | 19.2% | 21.7% | 20.6% | 20.8% | 16.8% | 17.0% | -62.7% | -735.3% | -202.0% | — | -1033.0% | -68.2% | -1.9% | 148.1% | -1799.2% | -1899.0% | -4898.5% | -261.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $136M | $146M | $388M | $228M | $102M | $65M | $242M | $158M | $65M |
| Capital Expenditures (CapEx) | $8M | $9M | $2M | $13M | $12M | $11M | $7M | $8M | $12M |
| Free Cash Flow (FCF) | $129M | $137M | $386M | $214M | $90M | $54M | $235M | $150M | $53M |
| FCF Margin % | 13.5% | 16.8% | 47.9% | 27.0% | 13.0% | 9.4% | 37.5% | 24.1% | 9.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.4B | $4.6B | $3.7B | $3.3B | $2.4B | $2.1B | $1.7B | $1.3B | $993M | $818M | $365M | $475M | $243M | $155M | $196M | $138M | $144M | $71M | $118M | $277M | $390M |
| Cash & Cash Equivalents | $332M | $713M | $233M | $251M | $263M | $341M | $187M | $112M | $142M | $255M | $83M | $74M | $31M | $45M | $64M | $50M | $54M | $37M | $68M | $100M | $81M |
| Total Liabilities | $1.7B | $1.4B | $1.1B | $1.0B | $661M | $698M | $608M | $669M | $512M | $445M | $50M | $50M | $34M | $34M | $42M | $78M | $125M | $67M | $81M | $158M | $75M |
| Total Debt (Short + Long-Term) | — | $0M | $0M | $170M | $169M | $352M | $328M | $818M | $451M | $408M | $15M | $12M | $0M | $0M | $11M | $8M | $9M | $4M | $8M | $110M | $54M |
| Total Shareholders' Equity | $3.7B | $3.3B | $2.6B | $2.2B | $1.7B | $1.4B | $1.1B | $637M | $481M | $372M | $315M | $424M | $209M | $120M | $154M | $60M | $19M | $4M | $37M | $119M | $315M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NBIX viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms